AUTHOR=Daher Gustavo , Santos-Bezerra Daniele Pereira , Cavaleiro Ana Mercedes , Pelaes Tatiana Souza , Admoni Sharon Nina , Perez Ricardo Vessoni , Machado Cleide Guimarães , Amaral Fernanda Gaspar do , Cipolla-Neto José , Correa-Giannella Maria Lúcia
TITLE=Rs4862705 in the melatonin receptor 1A gene is associated with renal function decline in type 1 diabetes individuals
JOURNAL=Frontiers in Endocrinology
VOLUME=15
YEAR=2024
URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1331012
DOI=10.3389/fendo.2024.1331012
ISSN=1664-2392
ABSTRACT=AimThe pathogenesis of chronic diabetes complications has oxidative stress as one of the major elements, and single-nucleotide polymorphisms (SNPs) in genes belonging to antioxidant pathways modulate susceptibility to these complications. Considering that melatonin is a powerful antioxidant compound, our aim was to explore, in a longitudinal cohort study of type 1 diabetes (T1D) individuals, the association of microvascular complications and SNPs in the gene encoding melatonin receptor 1A (MTNR1A).
MethodsEight SNPs in MTNR1A were genotyped in 489 T1D individuals. Besides cross-sectional analyses of SNPs with each one of the microvascular complications (distal polyneuropathy, cardiovascular autonomic neuropathy, retinopathy, and diabetic kidney disease), a longitudinal analysis evaluated the associations of SNPs with renal function decline in 411 individuals followed up for a median of 8 years. In a subgroup of participants, the association of complications with urinary 6-sulfatoxymelatonin (aMT6s) concentration was investigated.
ResultsThe group of individuals with a renal function decline ≥ 5 mL min−1 1.73 m−2 year−1 presented a higher frequency of the A allele of rs4862705 in comparison with nondecliners, even after adjustment for confounding variables (OR = 1.84, 95% CI = 1.20–2.82; p = 0.0046). No other significant associations were found.
ConclusionsThis is the first study showing an association between a variant in a gene belonging to the melatonin system and renal function decline in the diabetic setting.